PMC:7600245 / 26249-26455 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T98","span":{"begin":165,"end":173},"obj":"Disease"}],"attributes":[{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"The drug is currently being evaluated in a phase 2 double-blind, randomized, placebo-controlled study to determine its efficacy and safety in patients with moderate COVID-19 symptoms (NCT04396106; n = 190)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T240","span":{"begin":41,"end":42},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"The drug is currently being evaluated in a phase 2 double-blind, randomized, placebo-controlled study to determine its efficacy and safety in patients with moderate COVID-19 symptoms (NCT04396106; n = 190)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T369","span":{"begin":4,"end":8},"obj":"Chemical"}],"attributes":[{"id":"A369","pred":"chebi_id","subj":"T369","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"The drug is currently being evaluated in a phase 2 double-blind, randomized, placebo-controlled study to determine its efficacy and safety in patients with moderate COVID-19 symptoms (NCT04396106; n = 190)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T190","span":{"begin":0,"end":206},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The drug is currently being evaluated in a phase 2 double-blind, randomized, placebo-controlled study to determine its efficacy and safety in patients with moderate COVID-19 symptoms (NCT04396106; n = 190)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"721","span":{"begin":142,"end":150},"obj":"Species"},{"id":"733","span":{"begin":165,"end":173},"obj":"Disease"}],"attributes":[{"id":"A721","pred":"tao:has_database_id","subj":"721","obj":"Tax:9606"},{"id":"A733","pred":"tao:has_database_id","subj":"733","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The drug is currently being evaluated in a phase 2 double-blind, randomized, placebo-controlled study to determine its efficacy and safety in patients with moderate COVID-19 symptoms (NCT04396106; n = 190)."}